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Available online 14 January 2016The KCL013 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominantmutation affecting one allele of theHTT gene encoding huntingtin (42 trinucleotide repeats;
17 for the normal allele). The ICMwas isolated using laser microsurgery and plated on γ-irradiated human fore-
skinﬁbroblasts. Both the derivation and cell line propagationwere performed in an animal product-free environ-
ment. Pluripotent state and differentiation potential were conﬁrmed by in vitro assays.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
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Fig. 1.Genetic pedigree tree. The couple undergoing IVF had 12 embryos in this particular
cycle. Three embryos were normal, whereas nine carried the mutation in HTT and were
donated for research. We derived hESC lines from two of them.
Karyotype (G banding)
(Fig. 2)
No imbalance detected
Karyotype (aCGH) No imbalance detected
DNA ﬁngerprint
Allele sizes (in bp) of 17 microsatellite markers
speciﬁc for chromosomes 13, 18 and 21 (Ilic
et al., 2012)
Viability testing Pass
Pluripotent markers
(immunostaining)
(Fig. 3)
NANOG, OCT4, TRA-1-60, TRA-1-81, AP activity
(Ilic et al., 2012)
Three germ layer differentiation
in vitro (immunostaining)
(Fig. 4)
Endoderm: AFP (α-fetoprotein); ectoderm:
TUBB3 (tubulin, β3 class III); mesoderm: ACTA2
(actin, α2, smooth muscle) (Ilic et al., 2012)
Sibling lines available KCL012
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294 L. Jacquet et al. / Stem Cell Research 16 (2016) 293–295We generated KCL013 clinical grade hESC line following protocols,
established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkers was tested after freeze/thaw cycle
(Fig. 3; Ilic et al., 2012). Differentiation potential into three germ layers
was veriﬁed in vitro (Fig. 4; Ilic et al., 2012).Fig. 2. A modal karyotype (in 19 cells) showed a normal male chromosome complement and b
result of harvesting artifact.Materials and methods
Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent form
were mailed to them. If in the meantime new versions of PIS/consent
are implemented, we do not send these to the patients or ask them to
re-sign; the whole process is done with the version that was given
them initially. The PIS/consent documents (PGD-V.6) were created on
Aug. 10, 2007. HFEA Code of Practice that was in effect at the time of
document creation: Edition 7 — R.1 (http://www.hfea.gov.uk/2999.
html). The donor couple signed the consent on Oct. 15, 2009. HFEA
Code of Practice thatwas in effect at the time of donor signature: Edition
8— R.1. HFEA Code of Practice Edition 7— R.1was in effect until Dec. 09,
2007 and Edition 8 — R.1 was in effect: Oct. 01, 2009–Apr. 06, 2010.
Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).
Cell culture
ICM plated onmitotically inactivated HFF was cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). Trophectoderm cells were re-
moved mechanically from outgrowth (Ilic et al., 2007; Ilic et al., 2010).
hESC colonies were expanded and cryopreserved at the third passage.anding pattern. In addition, one anomalous cellwas seen (45,XY,−19), believed to be the
Fig. 3. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining (OCT4, NANOG, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Scale bar,
50 μm.
Fig. 4. Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smooth muscle actin (ACTA2, red) for mesoderm, β-III tubulin (TUBB3, red) for ectoderm andα-
fetoprotein (AFP, red) for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 100 μm.
295L. Jacquet et al. / Stem Cell Research 16 (2016) 293–295Viability test
Strawswith the earliest frozen passage (p. 2–3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cells were part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).
Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012).
Genotyping
DNA was extracted from hESC cultures using a Chemagen DNA ex-
traction robot according to the manufacturer's instructions. Ampliﬁca-
tion of polymorphic microsatellite markers was carried out as
described (Ilic et al., 2012). Allele sizes were recorded to give a unique
ﬁngerprint of each cell line.
Differentiation
Spontaneous differentiation into three germ layers was assessed
in vitro and in vivo as described (Petrova et al., 2014; Stephenson
et al., 2012).
Array comparative genomic hybridization (aCGH)
aCGH was performed as described in detail (Ilic et al., 2012).Author disclosure statement
There are no competing ﬁnancial interests in this study.
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